Page 10 - Memory Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U.S.-based pharmaceutical giant Merck & Co. on Friday, Oct. 1, said it would seek authorization for the first oral antiviral pill to treat COVID-19, after a clinical trial showed it cut the risk of hospitalization or death in half when given to high-risk people during infection.The drug, known as molnupiravir, was first shown to be efficacious against coronaviruses including the COVID-19 virus, SARS-CoV-2, by investigators in the lab of Mark Denison, MD, at Vanderbilt Universi .

Timothy sheahanMark denisonAndrea pruijssersEdward claiborne stahlmanEmory institute for drug developmentVanderbilt university medical centerUniversity of north carolina at chapel hillNational institutes of healthDrug administrationMerck coNorth carolinaMemory instituteDrug developmentMiami based ridgeback therapeuticsEdward claiborne stahlman chairPediatric physiology